Company Filing History:

11 out of 1,830

Sanofi-a Ventis Deutschland Gmbh

Aventis Pharma Deutschland, Gmbh

patents

Years Active: 2006-2011

Loading Chart...

13 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8048901 - 1,3-substituted cycloalkyl derivatives having acidic, mostly heterocyclic groups, processes for their preparation and their use as pharmaceuticals (2011-11-01),

2. 7956077 - 2-{-3,'2-(phenyl)-oxazol-4-ylmethoxyl-cyclohexyl methoxy}-propionic acid derivatives used as peroxisome proliferator-activated receptor (PPAR) ligands for the treatment of hyperlipidemia and diabetes (2011-06-07),

3. 7872034 - Arylcycloalkyl-substituted alkanoic acid derivatives, processes for their preparation and their use as pharmaceuticals (2011-01-18),

4. 7732471 - 6-oxazol-4-ylmetholmethoxy-alko-alkoxymethyl substituted benzoic acid derivatives forming peroxisome proliferator—activated receptor (PPAR) ligands, process for their preparation and methods of use thereof (2010-06-08),

5. 7598281 - Arylcycloakyl-substituted alkanoic acid derivatives useful as peroxisome proliferator-activated receptor (PPAR) ligands for the treatment of hyperlipidemia and diabetes (2009-10-06),

6. 7538131 - 2-{-3-'2-(phenyl)-oxazol-4-ylmethoxymethyl-cyclohexylmethoxy}-propionic acid derivatives useful as peroxisome proliferator-activated receptor (PPAR) ligands for the treatment of hyperlipidemia and diabetes (2009-05-26),

7. 7365084 - Cycloalkyl-substituted amino acid derivatives, processes for their preparation and their use as pharmaceuticals (2008-04-29),

8. 7335671 - Arylcycloalkyl-substituted alkanoic acid derivatives, processes for their preparation and their use as pharmaceuticals (2008-02-26),

9. 7259177 - Cycloalkylmethoxy-substituted acetic acid derivatives, processes for their preparation and their use as pharmaceuticals (2007-08-21),

10. 7220876 - Arylcycloalkyl derivatives having branched side chains, processes for their preparation and their use as pharmaceuticals (2007-05-22),

11. 7173151 - Cycloalkyl-substituted alkanoic acid derivatives, processes for their preparation and their use as pharmaceuticals (2007-02-06),

12. 7160911 - Diarylcycloalkyl derivatives, process for their preparation and their use as pharmaceuticals (2007-01-09),

13. 7148246 - Cycloalkyl derivatives having bioisosteric carboxylic acid groups, processes for their preparation and their use as pharmaceuticals (2006-12-12),

Title: Christian Stapper: Innovator in Pharmaceutical Chemistry

Introduction

Christian Stapper is a notable inventor based in Mainz, Germany. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds for treating metabolic disorders. With a total of 13 patents to his name, Stapper's work has the potential to impact the treatment of various health conditions.

Latest Patents

Stapper's latest patents include innovative compounds such as 1,3-substituted cycloalkyl derivatives that possess acidic, mostly heterocyclic groups. These compounds are designed for the treatment and prevention of disorders related to fatty acid metabolism and glucose utilization. The invention details processes for preparing these compounds and their physiologically acceptable salts. Another significant patent involves 2-{-3,'2-(phenyl)-oxazol-4-ylmethoxyl-cyclohexyl methoxy}-propionic acid derivatives, which serve as peroxisome proliferator-activated receptor (PPAR) ligands. These compounds are particularly useful in treating hyperlipidemia and diabetes, addressing insulin-related metabolic disorders.

Career Highlights

Throughout his career, Christian Stapper has worked with prominent companies in the pharmaceutical industry, including Sanofi-Aventis Deutschland GmbH and Sanofi-Aventis. His experience in these organizations has allowed him to develop and refine his innovative ideas in drug development.

Collaborations

Stapper has collaborated with notable colleagues such as Heiner Glombik and Eugen Falk. These partnerships have contributed to the advancement of his research and the successful development of his patented compounds.

Conclusion

Christian Stapper's contributions to pharmaceutical chemistry through his innovative patents highlight his role as a key inventor in the field. His work continues to pave the way for new treatments for metabolic disorders, showcasing the importance of innovation in healthcare.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com